Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -4.427% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] Cc1cc(C(=O)Nc2ccccc2C)n(-c2ccccc2)n1
[b] Cn1c(=O)c2c(nc(NCCNC(=O)c3ccco3)n2Cc2ccc(Cl)cc2Cl)n(C)c1=O
[c] COc1ccc2[nH]c3c(=O)n(/N=C/[C@H]4C(C)C=C(C)CC4C)c(=O)[nH]c3c2c1
[d] CCOc1ccc(NS(=O)(=O)c2ccc(C(=O)NCC(c3ccco3)N(C)C)cc2)cc1
[e] CCCCn1c(SCC(=O)NC2CCCC2)nc2ccccc2c1=O
Answer: e. CCCCn1c(SCC(=O)NC2CCCC2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(SCC(=O)NC2CCCC2)nc2ccccc2c1=O
CCCCn1c(SCC(=O)NC2CCCC2)nc2ccccc2c1=O
2-(3-butyl-4-oxoquinazolin-2-yl)sulfanyl-N-cyclopentylacetamide